Palo Alto, CA·Biotechnology, Pharmaceuticals, Healthcare·Last fund filed July 2023
Funds on file
4
Partners named
10
8 on a current fund
Recent board seats
3
last 24 months
Capital raised
$2.9B
across filed funds
What has Vivo Capital raised?
4 vehicles
Vehicle
Filed
Target
Sold to date
Investors
Vivo Capital Fund X, L.P.
July 2023
Indefinite
$717M
20
Vivo Capital Fund IX E&F, L.P.Filed to raise in 2019, with no closing reported yet.
2019
Indefinite
$0
0
Vivo Capital Fund IX, L.P.
August 2018
$1.4B
$1.4B
44
Vivo Capital Fund VIII, L.P.
December 2014
$750M
$750M
56
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
Who at Vivo Capital can lead a round?
10 named
10 partners are named across this firm’s filings, 8 of them on a fund it is deploying now.
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Food & agriculture
2 · 3%
Consumer apps & internet1 · 2%
Developer tools & infrastructure1 · 2%
Media & creator tools1 · 2%
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Vivo Capital’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
A shared board seat: a company where filings name a Vivo Capital partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
